Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments. The company offers...
4 insider purchases on record · latest filing 2020-08-26.
Insiders have also filed 305 sale transactions at SLP.